Abstract
Background: Coronavirus, called as, “the worst public health crisis for a generation,” is a malevolent silent killer.
Objective: One of the main concerns is containing the disease and avoiding the second wave of the pandemic, likely to arise because of the symptomatic patients, while ensuring the safe execution of day to day tasks.
Methods: The indirect transmission of coronavirus from asymptomatic individuals during incubation time and the identification of the people who have accidentally and unknowingly come in contact with infected but asymptomatic patients pose a significant challenge to the health care providers.
Results: Herein, for the first time, we have introduced a quantitative index; asymptomatic growth, to indicate whether the COVID-19 community spread is under control and if economic activities can be resumed.
Conclusion: More importantly, our system provides a feasible mechanism for improving the index to a level <1, a safety level at which normal economic activities can be conducted.
Keywords: COVID, asymptomatic, spread, corona, growth, asymptomatic growth.
Coronaviruses
Title:Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread
Volume: 2 Issue: 1
Author(s): Keith Lau*
Affiliation:
- iBonus Limited Unit 338, Building 16W Hong Kong Science Park, Shatin 8N.T.,Hong Kong
Keywords: COVID, asymptomatic, spread, corona, growth, asymptomatic growth.
Abstract:
Background: Coronavirus, called as, “the worst public health crisis for a generation,” is a malevolent silent killer.
Objective: One of the main concerns is containing the disease and avoiding the second wave of the pandemic, likely to arise because of the symptomatic patients, while ensuring the safe execution of day to day tasks.
Methods: The indirect transmission of coronavirus from asymptomatic individuals during incubation time and the identification of the people who have accidentally and unknowingly come in contact with infected but asymptomatic patients pose a significant challenge to the health care providers.
Results: Herein, for the first time, we have introduced a quantitative index; asymptomatic growth, to indicate whether the COVID-19 community spread is under control and if economic activities can be resumed.
Conclusion: More importantly, our system provides a feasible mechanism for improving the index to a level <1, a safety level at which normal economic activities can be conducted.
Export Options
About this article
Cite this article as:
Lau Keith *, Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread, Coronaviruses 2021; 2 (1) . https://dx.doi.org/10.2174/2666796701999200821160307
DOI https://dx.doi.org/10.2174/2666796701999200821160307 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Current Cancer Drug Targets Carbonic Anhydrase Inhibitors Developed Through ‘Click Tailing’
Current Pharmaceutical Design Pneumonia in the Burn Patient
Current Respiratory Medicine Reviews Immunomodulatory Therapeutic Effects of Curcumin on M1/M2 Macrophage Polarization in Inflammatory Diseases
Current Molecular Pharmacology Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease
Current Topics in Medicinal Chemistry Fructose-1,6-bisphosphatase Inhibitors: A Review of Recent (2000- 2017) Advances and Structure-Activity Relationship Studies
Current Medicinal Chemistry Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses Preface
Recent Patents on Anti-Cancer Drug Discovery A<sub>2A</sub> Adenosine Receptor Antagonists and their Potential in Neurological Disorders
Current Medicinal Chemistry Low Molecular Weight Compounds with Transition Metals as Free Radical Scavengers and Novel Therapeutic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Ventilation Therapy for Patients Suffering from Obstructive Lung Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms
Current Diabetes Reviews Selenium Status in Elderly People: Longevity and Age-Related Diseases
Current Pharmaceutical Design Recent Advances in Pathophysiology of Traumatic Brain Injury
Current Neuropharmacology Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Current Cancer Therapy Reviews Design, Synthesis and Biological Evaluation of Ferulic Acid Amides as Selective Matrix Metalloproteinase Inhibitors
Medicinal Chemistry Computational Approaches on Angiotensin Receptors and Their Ligands: Recent Developments and Results
Current Medicinal Chemistry Identification of Potential Mps1 Inhibitors Through Multiple Pharmacophore- based Virtual Screening and Molecular Docking
Letters in Drug Design & Discovery Clinical and Marketed Proteasome Inhibitors for Cancer Treatment
Current Medicinal Chemistry